Science-Based, Passion-Driven

We are advancing an innovative, high-value product portfolio for patients globally.

Learn More

Passion with Purpose

We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.

Learn More

Our Commitment to Patients

We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”

Learn More

BeiGene News

July 23, 2024

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World

Read more

July 18, 2024

BeiGene Announces Appointment of Aaron Rosenberg as Chief Financial Officer

Read more

June 14, 2024

BeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA® plus Venetoclax in High-Risk First-Line CLL/SLL at EHA2024

Read more

June 4, 2024

BeiGene to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Read more

May 24, 2024

BRUKINSA® Data at ASCO Underscore Differentiated Clinical Profile for Treatment of CLL and SLL

Read more

May 14, 2024

BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024

Read more